Back to GEODE CAPITAL MANAGEMENT, LLC GEODE CAPITAL MANAGEMENT, LLC

GALTGALT
Showing 8 of 31 quarters

Position history for GEODE CAPITAL MANAGEMENT, LLCGEODE CAPITAL MANAGEMENT, LLC's holdings in GALECTIN THERAPEUTICS INC

GEODE CAPITAL MANAGEMENT, LLC holds 1.3M shares of GALT (GALECTIN THERAPEUTICS INC), worth $6.1M as of 2026-Q2. The position was increased (+113.5% shares). GALT represents 0.0% of GEODE CAPITAL MANAGEMENT, LLC's portfolio.

Current Value

$6.1M

Current Shares

1.3M

Total Value Change

+$3.7M

Total Shares Change

+445,852

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1.3M
+113.5%
$6.1M0.0%$4.64
44
2026-Q1
Increased
612,786
+2.5%
$1.7M0.0%$2.98
26
2025-Q4
Decreased
598,074
-5.5%
$2.5M0.0%$4.08
0
2025-Q3
Decreased
633,067
-5.0%
$2.7M0.0%$4.22
0
2025-Q2
Decreased
666,191
-21.9%
$1.4M0.0%$2.33
0
2025-Q1
Decreased
852,706
-2.0%
$1M0.0%$1.52
0
2024-Q4
Increased
870,589
+0.9%
$1.1M0.0%$1.10
25
2024-Q3
Increased
862,542
+2.5%
$2.4M0.0%$2.71
27

Other major holders of GALT: BlackRock, Inc., VANGUARD CAPITAL MANAGEMENT LLC, VANGUARD GROUP INC, OSAIC HOLDINGS, INC.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used